LLY
Eli Lilly and Company
- Gross profit, 2025
- $54.1B
- YoY, 2025
- +47.8%
- 5-year CAGR
- +23.2%
- 10-year CAGR
- +13.8%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $54.1B | +47.8% |
| 2024 | $36.6B | +35.4% |
| 2023 | $27.0B | +23.4% |
| 2022 | $21.9B | +4.3% |
| 2021 | $21.0B | +10.2% |
| 2020 | $19.1B | +8.3% |
| 2019 | $17.6B | +4.7% |
| 2018 | $16.8B | +8.3% |
| 2017 | $15.5B | +0.1% |
| 2016 | $15.5B | +4.0% |
| 2015 | $14.9B | +1.6% |
| 2014 | $14.7B | −19.3% |
| 2013 | $18.2B | +2.2% |
| 2012 | $17.8B | −7.3% |
| 2011 | $19.2B | +2.7% |
| 2010 | $18.7B | +6.4% |
| 2009 | $17.6B | +10.0% |
| 2008 | $16.0B | +11.2% |
| 2007 | $14.4B | — |